ITOS
iTeos Therapeutics
ITOS
ITOS
Delisted
ITOS was delisted on the 28th of August, 2025.
136 hedge funds and large institutions have $396M invested in iTeos Therapeutics in 2023 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 47 increasing their positions, 39 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
5% less funds holding
Funds holding: 143 → 136 (-7)
14% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 36
86% less call options, than puts
Call options by funds: $2.04M | Put options by funds: $14.1M
Holders
136
Holding in Top 10
2
Calls
$2.04M
Puts
$14.1M
Top Buyers
| 1 | +$21.9M | |
| 2 | +$12.2M | |
| 3 | +$3.34M | |
| 4 |
Citigroup
New York
|
+$2.83M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.11M |
Top Sellers
| 1 | -$11.3M | |
| 2 | -$8.64M | |
| 3 | -$5.6M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$5.48M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.53M |